Navigation Links
Varian Medical Systems Makes Equity Investment and Obtains Option to Purchase Augmenix
Date:5/12/2011

learances or to comply with FDA and other regulatory regulations or procedures, changes in the regulatory environment, including with respect to FDA requirements, and other factors beyond the companies' control. For Varian, the risks and uncertainties include the other risks listed from time to time in its filings with the Securities and Exchange Commission, which by this reference are incorporated herein.  Neither Varian nor Augmenix assumes an obligation to update or revise the forward-looking statements in this release because of new information, future events or otherwise.

Augmenix and SpaceOAR are trademarks of Augmenix, Inc.

(1) Zelefsky MJ et al.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1111-6.

(2) Zelefsky MJ et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.  Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1124-9.

(3) Susil RC et al. Effects of prostate-rectum separation on rectal dose from external beam radiotherapy.  Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1251-8. Epub 2009 Nov 24.FOR INFORMATION CONTACT:Varian Medical Systems

AugmenixMeryl Ginsberg, 650-424-6444

Patrick Campbell, 781-902-1630  meryl.ginsberg@varian.com

pcampbell@augmenix.com
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Varian Medical Systems to Exhibit Full Spectrum of Prostate Cancer Treatment Approaches at the American Urological Association Meeting in Washington, D.C.
2. Varian Medical Systems Spotlights Fully Integrated Intensity Modulated Proton Therapy at PTCOG 2011 Meeting
3. Varian Medical Systems Spotlights Advanced Radiosurgery Systems at ISRS Congress in Paris, May 8-12
4. The ARIA® for Radiation Oncology Information System from Varian Medical Systems Now Certified by Surescripts® for E-Prescribing
5. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2011
6. FDA Grants Orphan Drug Designation for Nektars Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer
7. Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants
8. New Brachytherapy Applicator for Endometrial Cancer Patients Introduced at ABS 2011 by Varian Medical Systems
9. Varian Medical Systems to Exhibit the Latest Digital Image Detectors, X-Ray Tubes and Cancer Treatment Technologies at the CMEF Show in Shenzhen, China
10. Varian Medical Systems to Exhibit New TrueBeam™ System for Image-Guided Radiotherapy at ChinaMed Exhibition in Beijing
11. First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... 15, 2014  Over 200 patients, families, physicians ... to learn, interact and participate in the drive ... Lupus Trials Fair launched by the Lupus ... Lupus Foundation .  Attendees interacted directly with researchers ... experiences, ideas and needs and learning about more ...
(Date:9/15/2014)... 2014 Biomerics LLC, a leading provider ... announced its merger with Access Point Technologies and ... division was formed to provide next generation catheter ... structure heart, interventional radiology, interventional cardiology, and neurovascular ... will be led by Steve Berhow , ...
(Date:9/15/2014)... 2014 Chek Diagnostics, the U.S.-based manufacturer of ... point-of-care diagnostic products, has again been named to the ... companies in America. The Inc. 5000 ranking ... Chek Diagnostics earned its place on the list by ... 2013. For Chek Diagnostics, who appears on ...
Breaking Medicine Technology:Lupus Research Institute Launches NYC's First Lupus Trials Fair 2Lupus Research Institute Launches NYC's First Lupus Trials Fair 3Biomerics and Access Point Technologies OEM Announce Merger and Creation of Biomerics Advanced Catheter Division 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 2Chek Diagnostics Named to Inc. Magazine's 5000 Fastest Growing Private Companies List for the Fourth Time 3
... landmark trial provide important insight for physicians in treating ... Corporation (NYSE: BSX ) today welcomed the ... this week,s issue of the New England Journal of ... Cardiovascular Research Foundation with research grant support from Boston ...
... over linezolid in resistance acquisition by Staph aureus ... meetingSAN DIEGO, Calif., May 6 Trius Therapeutics, ... the treatment of serious bacterial infections, announced today ... lead program, torezolid (TR-701), will be presented in ...
Cached Medicine Technology:Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 2Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 3Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 4Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine 5Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases 2Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases 3
(Date:9/15/2014)... 2014 Array Health , ... today announced that Independence Blue Cross ... Pennsylvania, has selected the Array Spectrum™ Private Exchange ... marketplace for employers with more than 100 employees. ... Independence will offer employer groups a comprehensive selection ...
(Date:9/15/2014)... 2014 Providing additional expertise to ... LLP (“the Firm”) is proud to welcome ... with the Firm’s Litigation Support Services ... experience, Wolf will assist clients in litigation support, ... advisory matters. He will also provide guidance in ...
(Date:9/15/2014)... (PRWEB) September 15, 2014 Physicians ... this week, September 17-20, at the Lowes Coronado ... Plant-based Nutrition Healthcare Conference . This CME ... dietary-related advice—our physicians and healthcare professionals—about the nutritional ... food, plant-based nutrition and its proven ability to ...
(Date:9/15/2014)... (HealthDay News) -- People who,ve had a heart attack are ... critical steps in their treatment is missed, according to a ... patients who missed a part of their treatment early on, ... more likely to miss other steps in their care later ... patients can be improved if all nine steps critical to ...
(Date:9/15/2014)... sensitive means of analyzing very tiny amounts of DNA. ... forensic scientists to match genetic material in some criminal ... painful, invasive test given to transplant patients at risk ... a blood test that reveals traces of donor DNA. ... of The Journal of Molecular Diagnostics , the ...
Breaking Medicine News(10 mins):Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 2Health News:Independence Blue Cross Selects Array Spectrum™ Private Health Insurance Exchange Technology 3Health News:Cherry Bekaert Expands its Litigation Support Services Team Capabilities with the Addition of Steven Wolf 2Health News:Cherry Bekaert Expands its Litigation Support Services Team Capabilities with the Addition of Steven Wolf 3Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 2Health News:San Diego Plays Host This Week to International Plant-based Nutrition Healthcare Conference Featuring Drs. Ornish, Esselstyn, Campbell and Other Leading Experts 3Health News:Heart Attack Patients Face Greater Death Risk if Any Treatment Step Missed: Study 2Health News:Researchers develop improved means of detecting mismatched DNA 2
... to blood, bladder and ovarian malignancies, researchers say, , , ... at a tumor,s or patient,s genetics can provide important, ... So say scientists who outlined their research Tuesday in ... annual meeting, in Denver. , "This is an interesting ...
... Wainwright Bank & Trust Company (Nasdaq: WAIN ... complex New Markets Tax Credit financing structure for Hope House, ... job training and job placement for recovering alcoholics and substance ... Credit Allocation (as the controlling entity of AI Wainwright LLC) ...
... April 22 TOPICA Pharmaceuticals today announced the enrollment ... luliconazole for the treatment of tinea pedis (athlete,s foot). ... one of the most potent and broad spectrum molecules ... the potential to provide physicians and patients with a ...
... Misonix, Inc. (Nasdaq: MSON ), a developer ... Europe is used for the ablation of tumors and ... a definitive, 5-year distribution agreement with DTL Medical srl, ... the agreement, DTL will market the Sonablate(R) 500 High ...
... today that it will host its annual investor and analyst day on Thursday, ... Braintree, Massachusetts.The agenda for the meeting includes:, , ... Plasma Market Trends , ... R&D Progress , , , , ...
... combination of herbal ingredients contained in the anti-oxidant LiverLife ... reduce allergic responses in children with Autism Spectrum Disorder.LAGUNA ... brunt of the chemical age, accumulating toxins that weaken ... LiverLife(TM) significantly lowers the immune response ...
Cached Medicine News:Health News:Gene Studies Reveal Cancer's Secrets 2Health News:Gene Studies Reveal Cancer's Secrets 3Health News:Gene Studies Reveal Cancer's Secrets 4Health News:Gene Studies Reveal Cancer's Secrets 5Health News:Wainwright Bank Provides $10 Million in New Markets Tax Credits and $7.4 Million in Financing to Hope House 2Health News:TOPICA Begins Phase 2 Clinical Trial of Potent Antifungal, Luliconazole, in Athlete's Foot 2Health News:TOPICA Begins Phase 2 Clinical Trial of Potent Antifungal, Luliconazole, in Athlete's Foot 3Health News:Misonix Announces New HIFU Distribution Agreement for Romania and Bulgaria 2Health News:Misonix Announces New HIFU Distribution Agreement for Romania and Bulgaria 3Health News:Haemonetics Sets Date for Investor/Analyst Meeting 2Health News:BioRay's LiverLife Reduces Food Allergies in Autistic Children 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: